瑞銀:降中國外運(0598.HK)目標價至2.9港元 評級“買入”
瑞銀髮表報告稱,中國外運(0598.HK)今年首季純利為2.42億元人民幣,同比下跌58%,至於收入同比減少9%,主要由於內地及出口相關服務因公共衞生事件造成負面影響。
該行表示,雖然內地服務正恢復正常,但預期集團仍會繼續受到公共衞生事件帶來的負面影響,特別是內地出口相關服務。另外,集團授出的認股權要求在明年至2023年的盈利增長9.75%至10.5%,股本回報率要求為11.4%至11.8%,該行估計若沒有資產變現,有關目標預計難以達成。
該行下調中外運股份目標價,由3.2港元降至2.9港元,並稱估值低企,維持“買入”評級,下調集團今年至2022年的每股盈利預測分別23%、14%及14%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.